Literature DB >> 29285353

Triple-negative breast cancer and its association with obesity.

Heng Sun1,2, Jing Zou3, Ling Chen1, Xuyu Zu1, Gebo Wen1,2, Jing Zhong1.   

Abstract

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks expression of the estrogen and progesterone receptor and does not overexpress human epidermal growth factor 2 receptor protein. TNBC is associated with special characteristics, including aggressiveness, poor prognosis and poor response to treatment, and has been attracting increasing attention worldwide. Obesity is a well-documented factor exerting a significant effect on the development of breast cancer, including TNBC. The purpose of the present review was to focus on the association between obesity and TNBC and provide a summary of novel research findings. The aim was to highlight the association between TNBC and obesity and provide an overview of novel outlooks on clinical issues, biological rationale, novel targeted therapies and prognosis, in order to draw attention to the significance of weight management, primary prevention, early diagnosis and treatment of this intractable disease.

Entities:  

Keywords:  biological rationale; clinical issues; novel targeted therapies; obesity; prognosis; triple-negative breast cancer

Year:  2017        PMID: 29285353      PMCID: PMC5740844          DOI: 10.3892/mco.2017.1429

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  99 in total

Review 1.  The IGF-1 receptor in cancer biology.

Authors:  Renato Baserga; Francesca Peruzzi; Krysztof Reiss
Journal:  Int J Cancer       Date:  2003-12-20       Impact factor: 7.396

2.  Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells.

Authors:  Rita Nahta; Linda X H Yuan; Bing Zhang; Ryuji Kobayashi; Francisco J Esteva
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

4.  Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell.

Authors:  Jee Hyun Kang; Yoon Young Lee; Byung Yeon Yu; Beom-Seok Yang; Kyung-Hwan Cho; Do Kyoung Yoon; Yong Kyun Roh
Journal:  Arch Pharm Res       Date:  2005-11       Impact factor: 4.946

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study.

Authors:  Tanmai Saxena; Eunjung Lee; Katherine D Henderson; Christina A Clarke; Dee West; Sarah F Marshall; Dennis Deapen; Leslie Bernstein; Giske Ursin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-10       Impact factor: 4.254

7.  Metformin induces unique biological and molecular responses in triple negative breast cancer cells.

Authors:  Bolin Liu; Zeying Fan; Susan M Edgerton; Xin-Sheng Deng; Irina N Alimova; Stuart E Lind; Ann D Thor
Journal:  Cell Cycle       Date:  2009-07-21       Impact factor: 4.534

8.  Obesity and angiolymphatic invasion in primary breast cancer.

Authors:  Erin F Gillespie; Melony E Sorbero; David A Hanauer; Michael S Sabel; Emily J Herrmann; Laura J Weiser; Christina H Jagielski; Jennifer J Griggs
Journal:  Ann Surg Oncol       Date:  2009-11-07       Impact factor: 5.344

9.  Does obesity have an effect on outcomes in triple-negative breast cancer?

Authors:  Ronny Mowad; Quyen D Chu; Benjamin D L Li; Gary V Burton; Frederico L Ampil; Roger H Kim
Journal:  J Surg Res       Date:  2013-06-02       Impact factor: 2.192

10.  Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women.

Authors:  Hong-Liang Chen; Ang Ding; Mao-Li Wang
Journal:  Springerplus       Date:  2016-05-11
View more
  17 in total

1.  Association of Insulin Resistance and Higher Oncotype DX™ Recurrence Score.

Authors:  Nicole T Gordon; Jaime J Alberty-Oller; Kezhen Fei; Giampaolo Greco; Emily J Gallagher; Derek LeRoith; Sheldon M Feldman; Bridgid Killilea; Susan K Boolbol; Lydia Choi; Neil Friedman; Melissa Pilewskie; Elisa Port; Amy Tiersten; Nina A Bickell
Journal:  Ann Surg Oncol       Date:  2021-04-03       Impact factor: 5.344

2.  Escape from breast tumor dormancy: The convergence of obesity and menopause.

Authors:  Roopali Roy; Jiang Yang; Takaya Shimura; Lauren Merritt; Justine Alluin; Emily Man; Cassandra Daisy; Rama Aldakhlallah; Deborah Dillon; Susan Pories; Lewis A Chodosh; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-03       Impact factor: 12.779

3.  Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers.

Authors:  Kuo Chen; Jin Zhang; Narasimha M Beeraka; Chengyun Tang; Yulia V Babayeva; Mikhail Y Sinelnikov; Xinliang Zhang; Jiacheng Zhang; Junqi Liu; Igor V Reshetov; Olga A Sukocheva; Pengwei Lu; Ruitai Fan
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

4.  Metabolic Links to Socioeconomic Stresses Uniquely Affecting Ancestry in Normal Breast Tissue at Risk for Breast Cancer.

Authors:  Denys Rujchanarong; Danielle Scott; Yeonhee Park; Sean Brown; Anand S Mehta; Richard Drake; George E Sandusky; Harikrishna Nakshatri; Peggi M Angel
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

5.  Diet impacts triple-negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin-mediated cardiac dysfunction.

Authors:  Manuel U Ramirez; Kenysha Y J Clear; Zipporah Cornelius; Alaa Bawaneh; Yismeilin R Feliz-Mosquea; Adam S Wilson; Alistaire D Ruggiero; Nildris Cruz-Diaz; Lihong Shi; Bethany A Kerr; David R Soto-Pantoja; Katherine L Cook
Journal:  Physiol Rep       Date:  2022-04

Review 6.  Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.

Authors:  David N Brindley; Xiaoyun Tang; Guanmin Meng; Matthew G K Benesch
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

Review 7.  Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.

Authors:  Edit Mikó; Tünde Kovács; Éva Sebő; Judit Tóth; Tamás Csonka; Gyula Ujlaki; Adrienn Sipos; Judit Szabó; Gábor Méhes; Péter Bai
Journal:  Cells       Date:  2019-03-29       Impact factor: 6.600

Review 8.  Health Behaviors and Lifestyle Interventions in African American Breast Cancer Survivors: A Review.

Authors:  Raheem J Paxton; William Garner; Lorraine T Dean; Georgiana Logan; Kristen Allen-Watts
Journal:  Front Oncol       Date:  2019-01-22       Impact factor: 6.244

Review 9.  The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer.

Authors:  Adviti Naik; Arta Monir Monjazeb; Julie Decock
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

10.  CLCA2 expression is associated with survival among African American women with triple negative breast cancer.

Authors:  Kristen S Purrington; Jimmie Knight; Gregory Dyson; Rouba Ali-Fehmi; Ann G Schwartz; Julie L Boerner; Sudeshna Bandyopadhyay
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.